Andrew Cheng

Andrew Cheng

Chief Executive Officer presso AKERO THERAPEUTICS, INC.

Patrimonio netto: 16 M $ in data 31/03/2024

57 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Andrew Cheng is currently the President, Chief Executive Officer & Director at Akero Therapeutics, Inc., a Non-Executive Director at MorphoSys AG, an Independent Director at Vera Therapeutics, Inc., and a Director at Boys & Girls Clubs of Metro Los Angeles.
He previously served as an Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022, and held positions as a Director at Syntimmune, Inc., a Director at Global Virus Network, and the Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. from 1999 to 2018.
Dr. Cheng received his undergraduate degree from The Johns Hopkins University in 1988 and his doctorate from Columbia University College of Physicians & Surgeons in 1996.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/03/2024 589 447 ( 0.85% ) 15 M $ 31/03/2024
18/03/2024 17 488 ( 0.03% ) 754 083 $ 31/03/2024

Posizioni attive di Andrew Cheng

SocietàPosizioneInizio
AKERO THERAPEUTICS, INC. Chief Executive Officer 01/09/2018
VERA THERAPEUTICS, INC. Director/Board Member 01/05/2017
MORPHOSYS AG Director/Board Member 18/05/2022
Director/Board Member -
Tutte le posizioni attive di Andrew Cheng

Precedenti posizioni note di Andrew Cheng

SocietàPosizioneFine
ARBUTUS BIOPHARMA CORPORATION Director/Board Member 25/05/2022
GILEAD SCIENCES, INC. Chief Tech/Sci/R&D Officer 07/09/2018
Director/Board Member -
Director/Board Member -
Vedi nel dettaglio l'esperienza di Andrew Cheng

Formazione di Andrew Cheng

The Johns Hopkins University Undergraduate Degree
Columbia University College of Physicians & Surgeons Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew Cheng

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
GILEAD SCIENCES, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

MORPHOSYS AG

Health Technology

AKERO THERAPEUTICS, INC.

Health Technology

Aziende private4

Health Technology

Commercial Services

Vera Therapeutics, Inc.

Commercial Services

Vedi le connessioni aziendali